Literature DB >> 10841574

In vitro correlates of HIV-2-mediated HIV-1 protection.

E G Kokkotou1, J L Sankale, I Mani, A Gueye-Ndiaye, D Schwartz, M E Essex, S Mboup, P J Kanki.   

Abstract

A prospective study of high-risk commercial sex workers in Senegal has shown that HIV-2 infection may reduce the risk of subsequent HIV-1 infection; these findings have been confirmed and extended, now with 13 years of observation. While exploring the biological mechanisms behind this natural protection, we found that a significant proportion of peripheral blood mononuclear cells obtained from HIV-2-infected subjects resisted in vitro challenge with CCR5-dependent HIV-1 viruses but not CXCR4-dependent viruses. High levels of beta-chemokines, the natural ligands of the CCR5 coreceptor, were correlated with low levels of viral replication, and resistance was abrogated by antibodies to beta-chemokines. Our results suggest that beta-chemokine-mediated resistance may be an important correlate of HIV protection against HIV-1 infection and relevant to HIV vaccine design.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841574      PMCID: PMC18743          DOI: 10.1073/pnas.97.12.6797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  HIV-2 antisera cross-neutralize HIV-1.

Authors:  R A Weiss; P R Clapham; J N Weber; D Whitby; R S Tedder; T O'Connor; S Chamaret; L Montagnier
Journal:  AIDS       Date:  1988-04       Impact factor: 4.177

2.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

Authors:  T Zhu; H Mo; N Wang; D S Nam; Y Cao; R A Koup; D D Ho
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

3.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

4.  Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

Authors:  H Schmidtmayerova; H S Nottet; G Nuovo; T Raabe; C R Flanagan; L Dubrovsky; H E Gendelman; A Cerami; M Bukrinsky; B Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

5.  Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Authors:  W A Paxton; S R Martin; D Tse; T R O'Brien; J Skurnick; N L VanDevanter; N Padian; J F Braun; D P Kotler; S M Wolinsky; R A Koup
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

6.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Authors:  R Marlink; P Kanki; I Thior; K Travers; G Eisen; T Siby; I Traore; C C Hsieh; M C Dia; E H Gueye
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

7.  Natural protection against HIV-1 infection provided by HIV-2.

Authors:  K Travers; S Mboup; R Marlink; A Guèye-Nidaye; T Siby; I Thior; I Traore; A Dieng-Sarr; J L Sankalé; C Mullins
Journal:  Science       Date:  1995-06-16       Impact factor: 47.728

8.  Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.

Authors:  S K Arya; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  Slower heterosexual spread of HIV-2 than HIV-1.

Authors:  P J Kanki; K U Travers; S MBoup; C C Hsieh; R G Marlink; A Gueye-NDiaye; T Siby; I Thior; M Hernandez-Avila; J L Sankalé
Journal:  Lancet       Date:  1994-04-16       Impact factor: 79.321

10.  A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.

Authors:  A McKnight; M T Dittmar; J Moniz-Periera; K Ariyoshi; J D Reeves; S Hibbitts; D Whitby; E Aarons; A E Proudfoot; H Whittle; P R Clapham
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  6 in total

Review 1.  The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest.

Authors:  Hamayun J Sharifi; Andrea M Furuya; Carlos M C de Noronha
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

Review 2.  Update on human immunodeficiency virus (HIV)-2 infection.

Authors:  Omobolaji T Campbell-Yesufu; Rajesh T Gandhi
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

3.  Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection.

Authors:  Rui Soares; Russell Foxall; Adriana Albuquerque; Catarina Cortesão; Miguel Garcia; Rui M M Victorino; Ana E Sousa
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

4.  Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo.

Authors:  Adam MacNeil; Jean-Louis Sankalé; Seema Thakore Meloni; Abdoulaye Dieng Sarr; Souleymane Mboup; Phyllis Kanki
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 5.  Coinfecting viruses as determinants of HIV disease.

Authors:  Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

Review 6.  HIV-2 as a model to identify a functional HIV cure.

Authors:  Joakim Esbjörnsson; Marianne Jansson; Sanne Jespersen; Fredrik Månsson; Bo L Hønge; Jacob Lindman; Candida Medina; Zacarias J da Silva; Hans Norrgren; Patrik Medstrand; Sarah L Rowland-Jones; Christian Wejse
Journal:  AIDS Res Ther       Date:  2019-09-05       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.